The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
CT Radiogenomic Characterization of EGFR, K-RAS, and ALK Mutations in Non-Small Cell Lung Cancer
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lynch, T. J., Bell, D. W., Sordella, R., Gurubhagavatula, S., Okimoto, R. A., Brannigan, B. W., Harris, P. L., Haserlat, S. M., Supko, J. G., Haluska, F. G., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040938 · Cited by 11,486
Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
Gerlinger, M., Rowan, A. J., Horswell, S., Larkin, J., Endesfelder, D., Gronroos, E., Martinez, P., Matthews, N., Stewart, A., Tarpey, P., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1113205 · Cited by 7,774
Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer
Kwak, E. L., Bang, Y.-J., Camidge, D. R., Shaw, A. T., Solomon, B., Maki, R. G., Ou, S.-H. I., Dezube, B. J., Jänne, P. A., Costa, D. B., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1006448 · Cited by 4,446
Pathology and genetics of tumours of the lung , pleura, thymus and heart
Travis, W. D. (2004) · Cited by 1,955
Ceritinib in ALK -Rearranged Non–Small-Cell Lung Cancer
Shaw, A. T., Kim, D.-W., Mehra, R., Tan, D. S. W., Felip, E., Chow, L. Q. M., Camidge, D. R., Vansteenkiste, J., Sharma, S., De Pas, T., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1311107 · Cited by 1,495
Measurement of Observer Agreement
Kundel, H. L., & Polansky, M. (2003) · Radiology · doi:10.1148/radiol.2282011860 · Cited by 1,492
K-ras Oncogene Activation as a Prognostic Marker in Adenocarcinoma of the Lung
Slebos, R. J. C., Kibbelaar, R. E., Dalesio, O., Kooistra, A., Stam, J., Meijer, C. J. L. M., Wagenaar, S. S., Vanderschueren, R. G. J. R. A., van Zandwijk, N., Mooi, W. J., et al. (1990) · New England Journal of Medicine · doi:10.1056/nejm199008303230902 · Cited by 809
Linardou, H., Dahabreh, I. J., Kanaloupiti, D., Siannis, F., Bafaloukos, D., Kosmidis, P., Papadimitriou, C. A., & Murray, S. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70206-7 · Cited by 739
Frequency and Distinctive Spectrum of KRAS Mutations in Never Smokers with Lung Adenocarcinoma
Riely, G. J., Kris, M. G., Rosenbaum, D., Marks, J., Li, A., Chitale, D. A., Nafa, K., Riedel, E. R., Hsu, M., Pao, W., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0646 · Cited by 578
Seto, T., Kiura, K., Nishio, M., Nakagawa, K., Maemondo, M., Inoue, A., Hida, T., Yamamoto, N., Yoshioka, H., Harada, M., et al. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70142-6 · Cited by 575
Gevaert, O., Xu, J., Hoang, C. D., Leung, A. N., Xu, Y., Quon, A., Rubin, D. L., Napel, S., & Plevritis, S. K. (2012) · Radiology · doi:10.1148/radiol.12111607 · Cited by 398
Never-Smokers With Lung Cancer: Epidemiologic Evidence of a Distinct Disease Entity
Toh, C.-K., Gao, F., Lim, W.-T., Leong, S.-S., Fong, K.-W., Yap, S.-P., Hsu, A. A. L., Eng, P., Koong, H.-N., Thirugnanam, A., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.8033 · Cited by 379
Clinical significance of ras oncogene activation in human lung cancer
(1993) · Lung Cancer · doi:10.1016/0169-5002(93)90536-7 · Cited by 360
Radiogenomics: Creating a link between molecular diagnostics and diagnostic imaging
Rutman, A. M., & Kuo, M. D. (2009) · European Journal of Radiology · doi:10.1016/j.ejrad.2009.01.050 · Cited by 321
Mao, C., Qiu, L.-X., Liao, R.-Y., Du, F.-B., Ding, H., Yang, W.-C., Li, J., & Chen, Q. (2010) · Lung Cancer · doi:10.1016/j.lungcan.2009.11.020 · Cited by 313
Karlo, C. A., Di Paolo, P. L., Chaim, J., Hakimi, A. A., Ostrovnaya, I., Russo, P., Hricak, H., Motzer, R., Hsieh, J. J., & Akin, O. (2014) · Radiology · doi:10.1148/radiol.13130663 · Cited by 270
Kuo, M. D., & Jamshidi, N. (2014) · Radiology · doi:10.1148/radiol.13132195 · Cited by 239
Jain, R., Poisson, L. M., Gutman, D., Scarpace, L., Hwang, S. N., Holder, C. A., Wintermark, M., Rao, A., Colen, R. R., Kirby, J., et al. (2014) · Radiology · doi:10.1148/radiol.14131691 · Cited by 234
Genomic analysis of genetic heterogeneity and evolution in high-grade serous ovarian carcinoma
Cooke, S. L., Ng, C. K. Y., Melnyk, N., Garcia, M. J., Hardcastle, T., Temple, J., Langdon, S., Huntsman, D., & Brenton, J. D. (2010) · Oncogene · doi:10.1038/onc.2010.245 · Cited by 178
Lee, H.-J., Kim, Y. T., Kang, C. H., Zhao, B., Tan, Y., Schwartz, L. H., Persigehl, T., Jeon, Y. K., & Chung, D. H. (2013) · Radiology · doi:10.1148/radiol.13112553 · Cited by 176
Rivera, G. A., & Wakelee, H. (2016) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-319-24223-1_3 · Cited by 174
ALK Molecular Phenotype in Non–Small Cell Lung Cancer: CT Radiogenomic Characterization
Yamamoto, S., Korn, R. L., Oklu, R., Migdal, C., Gotway, M. B., Weiss, G. J., Iafrate, A. J., Kim, D.-W., & Kuo, M. D. (2014) · Radiology · doi:10.1148/radiol.14140789 · Cited by 159
KRAS Mutations as Prognostic and Predictive Markers in Non–Small Cell Lung Cancer
Martin, P., Leighl, N. B., Tsao, M., & Shepherd, F. A. (2013) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e318283d958 · Cited by 142
Epidermal growth factor receptor (EGFR) mutations in lung cancer: preclinical and clinical data
Jorge, S. E., Kobayashi, S. S., & Costa, D. B. (2014) · Brazilian Journal of Medical and Biological Research · doi:10.1590/1414-431x20144099 · Cited by 131
Buettner, R., Wolf, J., & Thomas, R. K. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.45.9867 · Cited by 127
Clinicopathological predictors of EGFR/KRAS mutational status in primary lung adenocarcinomas
Đačić, S., Shuai, Y., Yousem, S. A., Ohori, P. N., & Nikiforova, M. N. (2009) · Modern Pathology · doi:10.1038/modpathol.2009.154 · Cited by 116
Management and Future Directions in Non-Small Cell Lung Cancer with Known Activating Mutations
Gerber, D. E., Gandhi, L., & Costa, D. B. (2014) · American Society of Clinical Oncology Educational Book · doi:10.14694/edbook_am.2014.34.e353 · Cited by 91
Hsu, J., Huang, M., Chen, C., Liu, G., Liu, T., Chong, I., Chou, S., & Yang, C. (2014) · Journal of Thoracic Imaging · doi:10.1097/rti.0000000000000116 · Cited by 73
Colen, R. R., Foster, I. T., Gatenby, R. A., Giger, M. L., Gillies, R. J., Gutman, D. A., Heller, M. T., Jain, R., Madabhushi, A., Madhavan, S., et al. (2014) · Translational Oncology · doi:10.1016/j.tranon.2014.07.007 · Cited by 72
Ou, S. I. (2013) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2012-201296 · Cited by 39
Đačić, S. (2013) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2012-201336 · Cited by 38
Cited by
Radiomics: the bridge between medical imaging and personalized medicine
Lambin, P., Leijenaar, R. T. H., Deist, T. M., Peerlings, J., de Jong, E. E. C., van Timmeren, J., Sanduleanu, S., Larue, R. T. H. M., Even, A. J. G., Jochems, A., et al. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2017.141 · Cited by 5,688
Radiomics: the facts and the challenges of image analysis
Rizzo, S., Botta, F., Raimondi, S., Origgi, D., Fanciullo, C., Morganti, A. G., & Bellomi, M. (2018) · European Radiology Experimental · doi:10.1186/s41747-018-0068-z · Cited by 1,054
Self-citationRadiomics and radiogenomics in lung cancer: A review for the clinician
Thawani, R., McLane, M., Beig, N., Ghose, S., Prasanna, P., Velcheti, V., & Madabhushi, A. (2018) · Lung Cancer · doi:10.1016/j.lungcan.2017.10.015 · Cited by 450
Somatic Mutations Drive Distinct Imaging Phenotypes in Lung Cancer
Rios Velazquez, E., Parmar, C., Liu, Y., Coroller, T. P., Cruz, G., Stringfield, O., Ye, Z., Makrigiorgos, M., Fennessy, F., Mak, R. H., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-0122 · Cited by 391
Defining the biological basis of radiomic phenotypes in lung cancer
Grossmann, P., Stringfield, O., El-Hachem, N., Bui, M. M., Rios Velazquez, E., Parmar, C., Leijenaar, R. T., Haibe-Kains, B., Lambin, P., Gillies, R. J., et al. (2017) · eLife · doi:10.7554/elife.23421 · Cited by 365
Metadata
- Authors
- Rizzo, S., Petrella, F., Buscarino, V., De Maria, F., Raimondi, S., Barberis, M., Fumagalli, C., Spitaleri, G., Rampinelli, C., De Marinis, F., Spaggiari, L., & Bellomi, M.
- Venue
- European Radiology
- Published
- 2015-05-09
- Volume
- 26
- Issue
- 1
- Pages
- 32-42
- ISSN
- 0938-7994 (ISSN-L)
- 1432-1084
- OpenAlex
- W828015039
- Cited by
- 270
- References
- 31
- FWCI
- 15.03
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.